Paul J. Durack is a climate scientist at Lawrence Livermore National Laboratory, Livermore, California, USA. Carlo Buontempo is director of the Copernicus Climate Change Service at the European Centre ...

A recent study in Nature Communications highlights a key challenge in single-cell proteomics: protein leakage. Focusing on murine tracheal cells, the research team examined how leakage can skew ...

Another cell therapy biotech has run out of steam, this time before ever reaching the clinic. California CAR-T company Appia Bio has closed up shop, founding CEO JeenJoo “JJ” Kang, Ph.D., wrote in an ...

First chemotherapy-free trial combining ANKTIVA, an IL-15 agonist, natural killer (NK) cell therapy, and Optune immune-stimulating device for patients with glioblastoma (GBM) brain tumors who have ...

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the ...

For life to function, cell membranes must remain intact. When these fragile barriers are damaged – for instance by heat or viral attack – specialized proteins come to the rescue. Researchers at ...

Our second ever Global B2B Marketing Agencies Benchmarking Report is back and it is showcasing the best-of-the-best in B2B across the globe, from the UK to the US and beyond. If you're looking for ...